Using AI to analyze heart changes in patients with high blood pressure
Official title: Echocardiographic Analysis by Artificial Intelligence in Hypertension
Run by Hospices Civils de Lyon · NCT06680986 · Data updated 2026-11-12
This study is testing if artificial intelligence can help doctors understand heart changes in patients with high blood pressure by analyzing their heart scans and health information.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Status | Recruiting |
| Started | June 1, 2022 |
| Main results expected | December 31, 2022 |
| Study ends | December 31, 2024 |
| Registry record updated | November 8, 2024 |
| Trial ID | NCT06680986 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults who have undergone comprehensive blood pressure assessments during hospitalization for hypertension.
✕Probably not a fit
Patients who are minors or those under curatorship or guardianship will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop artificial intelligence tools to analyze echocardiographic data and patient information to better understand cardiac remodeling in individuals with arterial hypertension. By examining routine imaging data, the study seeks to characterize the spectrum of cardiac effects in hypertensive patients, particularly those in ambiguous clinical situations. The research will also focus on creating automated methods for quantifying cardiac function, enhancing the descriptors used in clinical practice for monitoring heart health.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and treatment strategies for patients with arterial hypertension.
How similar studies have gone: While the use of AI in medical imaging is gaining traction, this specific approach to analyzing cardiac remodeling in hypertension is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Patients who underwent a comprehensive blood pressure assessment during hospitalization in the Cardiologic Federation at Croix Rousse Hospital and Lyon Sud Hospital between January 2018 and December 2021. Exclusion Criteria Patients who are minors. Patients under curatorship or guardianship.
Where it's running
-
Hopital Lyon Sud
Pierre-Bénite, France Recruiting
Study contacts
- Study coordinator: PierreYves COURAND, MD
- Email: pierre-yves.courand@chu-lyon.fr
- Phone: (+33) 04 78 86 57 37
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational register of adults with diabetes and endocrine/metabolic disorders
This study will collect medical information from adults with diabetes or related metabolic and endocrine conditions to see how markers relate to disease severity and progression.
-
Reliability of Two-Stage Multiple-Repetition-Maximum Tests to Estimate 1-RM in People with Heart Disease and Risk Factors
This study checks how well different formulas estimate the 1-RM from two submaximal tests in adults with heart disease or risk factors.
-
Registry for studying hypertension types and treatment in Morocco
This study is collecting health information from adults with high blood pressure in Morocco to see how different types of hypertension are treated and to improve care for patients.
-
Telemedical support for managing high blood pressure
This study is testing a new remote blood pressure monitoring system to see if it helps doctors better manage high blood pressure in adults who have trouble controlling it.
-
Nitrate supplementation effects on blood pressure in resistant hypertension patients
This study tests if taking beetroot extract can help lower blood pressure in people with resistant hypertension who haven't changed their blood pressure medications recently.
-
Using Fetuin A to Predict Kidney Function Decline in Patients with High Blood Pressure
This study is testing if a substance in urine called Fetuin A can help predict kidney problems in people with high blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.